欧陆-欧陆娱乐-欧陆注册【高质量一站式服务】

Poly Pharm adheres to the advanced manufacturing positioning of "differentiation + vertical integration of API and finished product  + internationalization", strictly requiring drug quality comply with international GMP  standards. It has established a complete quality system, standardized quality management and control systems, procedures and standards. The company has accumulated rich technical reserves and experience in drug formulation technology research and formulation global registration. In recent years, the company has continuously increased its R&D investment in the combination of"generic and innovative" research, targeting at those products with high technical difficulty and differentiation, and it has established an innovative drug research institute, a biotechnology research institute, a generic drug research institute, and a API research institute, with over 550 R&D personnel, accounting for one-third of the company's total employees.